Literature DB >> 4117299

Reducing body myopathy.

M H Brooke, H E Neville.   

Abstract

Entities:  

Mesh：

Year:  1972        PMID： 4117299     DOI： 10.1212/wnl.22.8.829

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  19 in total

Review 1.  Myofibrillar myopathies: new developments.

Authors:  Montse Olivé; Rudolf A Kley; Lev G Goldfarb
Journal:  Curr Opin Neurol       Date:  2013-10       Impact factor: 5.710

2.  Department of Neurology, Northwestern University Medical School, Chicago, Illinois.

Authors:  V Sahgal; S Sahgal
Journal:  Acta Neuropathol       Date:  1977-03-31       Impact factor: 17.088

3.  Congenital myopathy with "reducing bodies" in muscle fibres.

Authors:  F M Tomé; M Fardeau
Journal:  Acta Neuropathol       Date:  1975       Impact factor: 17.088

4.  169th ENMC International Workshop Rare Structural Congenital Myopathies 6-8 November 2009, Naarden, The Netherlands.

Authors:  Hans H Goebel; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2011-03-29       Impact factor: 4.296

5.  Reducing bodies in distal myopathy with rimmed vacuole formation.

Authors:  B H Kiyomoto; N Murakami; J Kishibayashi; N Sunohara; I Nonaka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.

Authors:  Joachim Schessl; Ana L Taratuto; Caroline Sewry; Roberta Battini; Steven S Chin; Baijayanta Maiti; Alberto L Dubrovsky; Marcela G Erro; Graciela Espada; Monica Robertella; Maria Saccoliti; Patricia Olmos; Leslie R Bridges; Peter Standring; Ying Hu; Yaqun Zou; Kathryn J Swoboda; Mena Scavina; Hans-Hilmar Goebel; Christina A Mitchell; Kevin M Flanigan; Francesco Muntoni; Carsten G Bönnemann
Journal:  Brain       Date:  2009-01-29       Impact factor: 13.501

7.  "Reducing body"-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency.

Authors:  V Jay; J Christodoulou; A Mercer-Connolly; R R McInnes
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

8.  Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.

Authors:  Joachim Schessl; Yaqun Zou; Meagan J McGrath; Belinda S Cowling; Baijayanta Maiti; Steven S Chin; Caroline Sewry; Roberta Battini; Ying Hu; Denny L Cottle; Michael Rosenblatt; Lynn Spruce; Arupa Ganguly; Janbernd Kirschner; Alexander R Judkins; Jeffrey A Golden; Hans-Hilmar Goebel; Francesco Muntoni; Kevin M Flanigan; Christina A Mitchell; Carsten G Bönnemann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

9.  Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders.

Authors:  Edoardo Malfatti; Montse Olivé; Ana Lía Taratuto; Pascale Richard; Guy Brochier; Marc Bitoun; Lucie Gueneau; Pascal Laforêt; Tanya Stojkovic; Thierry Maisonobe; Soledad Monges; Fabiana Lubieniecki; Gabriel Vasquez; Nathalie Streichenberger; Emmanuelle Lacène; Maria Saccoliti; Bernard Prudhon; Marilena Alexianu; Dominique Figarella-Branger; Joachim Schessl; Carsten Bonnemann; Bruno Eymard; Michel Fardeau; Gisèle Bonne; Norma Beatriz Romero
Journal:  J Neuropathol Exp Neurol       Date:  2013-09       Impact factor: 3.685

10.  Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.

Authors:  Belinda S Cowling; Meagan J McGrath; Mai-Anh Nguyen; Denny L Cottle; Anthony J Kee; Susan Brown; Joachim Schessl; Yaqun Zou; Josephine Joya; Carsten G Bönnemann; Edna C Hardeman; Christina A Mitchell
Journal:  J Cell Biol       Date:  2008-12-15       Impact factor: 10.539
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.